Wealth Enhancement Advisory Services
DNA icon

Wealth Enhancement Advisory Services’s Ginkgo Bioworks DNA Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$203K Buy
22,345
+10,438
+88% +$87.3K ﹤0.01% 3572
2026
Q1 		$82.2K Buy
+11,907
New +$99K ﹤0.01% 3355
2024
Q1 		– Sell
-286
Closed -$19.3K – 2503
2023
Q4 		$19.3K Sell
286
-37
-11% -$2.27K ﹤0.01% 2257
2023
Q3 		$23.4K Buy
+323
New +$25.8K ﹤0.01% 2191

Other funds holding DNA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return

Wealth Enhancement Advisory Services's DNA Position: Q2 2026 in Review

Wealth Enhancement Advisory Services increased its Ginkgo Bioworks (DNA) stake by 88% in Q2 2026, buying an estimated $87.3K and bringing the position to 22,345 shares worth $203K. The position accounts for ﹤0.01% of the portfolio, ranked #3572.

Wealth Enhancement Advisory Services first reported a position in DNA in Q3 2023 and has held it in 4 quarters since. 183 funds tracked by Wall St. Rank hold DNA as of Q2 2026.

  • Wealth Enhancement Advisory Services held 22,345 shares of Ginkgo Bioworks worth $203K as of Q2 2026.
  • Wealth Enhancement Advisory Services bought 10,438 Ginkgo Bioworks shares in Q2 2026, an estimated $87.3K.
  • Ginkgo Bioworks made up ﹤0.01% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #3572 holding.
  • Wealth Enhancement Advisory Services first reported a position in Ginkgo Bioworks in Q3 2023 and has held it in 4 quarters since.
  • 183 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.